3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia
1
Head and Neck Neoplasms
1
Carcinoma
1
Interventions
fludarabine
7
Whole-Body Irradiation
6
Cyclophosphamide
6
venetoclax
5
fludarabine phosphate
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Busulfan
4
asciminib
3
gilteritinib
2
blinatumomab
2
aldesleukin
2
Patient Reported Outcome Measures
2
Mesna
2
Melphalan
2
Interleukin-2
2
Idarubicin
2
Cytarabine
2
Bone Marrow Transplantation
2
Azacitidine
2
ponatinib
1
nilotinib
1
nicotinamide-beta-riboside
1
methanesulfonic acid
1
enasidenib
1
Thiotepa
1
Stem Cell Transplantation
1
Social Determinants of Health
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
IPI-549
×
1 year
×
Clear all
NCT07439211
2026-03-03
GAVEL
Dana-Farber Cancer Institute
Phase 1
Not yet recruiting
48 enrolled